Dual GIP/GLP-1 agonists, such as tirzepatide, show greater reductions in weight and blood sugar than GLP-1-only medications
After Jeremiah ended up in the ER for severe stomach pain, his pediatrician was alarmed by the amount of weight he had gained during the pandemic, which contributed to pre-diabetes, and suggested some lifestyle and behavioral changes
Significant demand for weight-management medicines has impacted the availability of Novo Nordisk obesity medications, including Saxenda
This dual action not only carries the benefits of GLP-1 receptor agonism but also adds the effects of GIP, which is involved in energy expenditure and also plays a role in insulin sensitivity
Select clinics that manage insurance coverage, including prior authorization and paperwork, relieving you from these administrative tasks